Professional Documents
Culture Documents
Uterus
Ovary
Vagina
Cervix
This is the uncontrolled growth of some cells on the cervix [the mouth of the womb]. Cells on the cervix begin to grow slowly and abnormally over several years.
These early (pre-cancerous) changes can grow into cancer if they are not identified [screening] and treated early.
Symptom free- Women are usually healthy looking and the condition is usually painless in early stages Irregular / intermenstrual or contact vaginal bleeding Foul vaginal discharge that never improves with treatment Pain (deep pelvic or back pain) In advanced cases; severe anaemia, renal failure, fistulae (rectal/vesico-vaginal), lymphoedema
Actual magnitude is unknown-no national data Cacx data not captured by HMIS National cancer registry-covers Kyaddondo county
Among female cancers Cervical cancer accounts for 40% of cancers Breast cancer accounts for 23% Others account for 37% Cacx accounts for over 80% of female cancers
Clinical Reports
Cervical cancer patients occupy 30% - 50% of Gyne beds at Mulago & RRH . Over 80% of women with cacx are diagnosed with advanced disease. Stage III.
Over 40% of radiotherapy patients have cacx. From admission to diagnosis is 2 to 4 weeks.
Leading cause of Gynaecological deaths Almost all cases advanced. Facilities to screen and treat are limited. Skills to diagnose & treat are limited as most cases are missed as STIs. The symptoms are mistaken with those of other gyne conditions Women suffer silently and do not report Only about 5% of women ever get access to screening.
Human papillomavirus (HPV) types 16 & 18. 99.7% of cervical cancer cases are associated with HPV
Prevalence of high-risk HPV infection No organized screening programs, despite many efforts Competing health problems Limited awareness of cost effective approaches to prevention Until recently, no vaccine was available to prevent infection Symptom free and goes unnoticed till late
Treatment of pre-cancer (cryotherapy, LEEP), For early invasive cacx (surgery, radiotherapy), For inoperable disease (Radiotherapy, Palliative care)
Commitment:
Inability to scale up & sustain pilot screening projects inspite of available evidence. Lack of commitment from policy makers to prioritize cancer control.
Lack of prioritization of women's sexual & Reproductive Health Failure to allocate resources to Cervical & other Cancers control programs. Lack of enabling policies & evidence based guidelines Competing priorities- ? HIV, TB, Malaria?
Lack of awareness that Cervical Cancer and other RH cancers are a major health problem among the population, health care providers' leaders & policy makers. Poor attitudes, misconceptions & beliefs that cancer is untreatable & therefore a death sentence. [stigma surrounding diseases of genital tract]. Failure to openly discuss issues related to sex & diseases of the genital tract presents major barriers to RH & cervical cancer control. Lack of symptoms at stages where treatment is effective.
Equipment maybe locked up Lack of facilitative supervision HMIS not capturing cancer data-burden unknown! Failure of H/W to recognize cacx as a big problem
lack of appropriate equipment, and Lack of skills among providers limits access to prevention activities, screening, diagnosis treatment, follow up and palliative care.
RH policy & Service standards Policy goal is to enhance integration of services for; Screening cervical & breast cancers Treatment of RH cancers in both men & women
PATH on the Cervical Cancer Vaccine project & already supporting Secondary prevention and National scale up plan IEC & Advocacy
Others are
ABNORMAL
Colposco py
ABNORMAL
Cryothera py
Formative Research Demonstration project Financial analysis Secondary prevention National scale-up Advocacy and communication Financial analysis
Objective: To strengthen the capacity of developing countries to prevent cervical cancer through generating and providing necessary evidence about publicsector introduction of cervical cancer vaccines.
PATH picture
Objective: To assess feasibility of schoolbased strategy for reaching girls in school aged 10-12 years, plus additional strategy for reaching girls out of school, possibly synchronized with semi-annual Child Health Days